Clover Health Investments, CORP /DE 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
Clover Health reported a net loss of $85.5 million for 2025, despite significant revenue growth and increased Medicare Advantage membership, as it continues to invest in its AI-powered Clover Assistant platform and expand its Counterpart Health subsidiary.
NASDAQ
Clover Health's 2024 10-K filing highlights membership growth, strategic shifts towards PPO plans and SaaS offerings, and ongoing efforts to improve financial performance and regulatory compliance.
NASDAQ
Clover Health Investments Corp. released its 2023 annual report, detailing financial performance and the strategic decision to exit the ACO REACH program.